nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—CYP2D6—Citalopram—alcohol dependence	0.194	0.396	CbGbCtD
Ranolazine—CYP3A4—Disulfiram—alcohol dependence	0.173	0.353	CbGbCtD
Ranolazine—CYP3A4—Citalopram—alcohol dependence	0.123	0.251	CbGbCtD
Ranolazine—Upset stomach—Disulfiram—alcohol dependence	0.013	0.0317	CcSEcCtD
Ranolazine—Dermatitis atopic—Disulfiram—alcohol dependence	0.0115	0.0281	CcSEcCtD
Ranolazine—Peripheral coldness—Naltrexone—alcohol dependence	0.00836	0.0203	CcSEcCtD
Ranolazine—Dizziness postural—Citalopram—alcohol dependence	0.00722	0.0176	CcSEcCtD
Ranolazine—Chromaturia—Citalopram—alcohol dependence	0.00706	0.0172	CcSEcCtD
Ranolazine—Upset stomach—Naltrexone—alcohol dependence	0.00608	0.0148	CcSEcCtD
Ranolazine—Cold sweat—Citalopram—alcohol dependence	0.00594	0.0144	CcSEcCtD
Ranolazine—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00569	0.0612	CbGpPWpGaD
Ranolazine—CYP2D6—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00557	0.06	CbGpPWpGaD
Ranolazine—Peripheral coldness—Citalopram—alcohol dependence	0.0053	0.0129	CcSEcCtD
Ranolazine—Throat tightness—Citalopram—alcohol dependence	0.00514	0.0125	CcSEcCtD
Ranolazine—Abdominal discomfort—Disulfiram—alcohol dependence	0.00514	0.0125	CcSEcCtD
Ranolazine—Erectile dysfunction—Disulfiram—alcohol dependence	0.00494	0.012	CcSEcCtD
Ranolazine—CYP2D6—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00462	0.0497	CbGpPWpGaD
Ranolazine—Creatinine increased—Acamprosate—alcohol dependence	0.00442	0.0107	CcSEcCtD
Ranolazine—Hypoaesthesia—Disulfiram—alcohol dependence	0.00427	0.0104	CcSEcCtD
Ranolazine—Electrocardiogram QT prolonged—Citalopram—alcohol dependence	0.00393	0.00955	CcSEcCtD
Ranolazine—CYP2D6—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00392	0.0423	CbGpPWpGaD
Ranolazine—Upset stomach—Citalopram—alcohol dependence	0.00385	0.00936	CcSEcCtD
Ranolazine—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00364	0.0392	CbGpPWpGaD
Ranolazine—Dermatitis atopic—Citalopram—alcohol dependence	0.00341	0.00829	CcSEcCtD
Ranolazine—CYP2D6—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00334	0.0359	CbGpPWpGaD
Ranolazine—Renal failure acute—Acamprosate—alcohol dependence	0.00331	0.00804	CcSEcCtD
Ranolazine—Amnesia—Acamprosate—alcohol dependence	0.00325	0.0079	CcSEcCtD
Ranolazine—Disorientation—Naltrexone—alcohol dependence	0.00323	0.00785	CcSEcCtD
Ranolazine—Hot flush—Naltrexone—alcohol dependence	0.00309	0.00751	CcSEcCtD
Ranolazine—Menopausal symptoms—Naltrexone—alcohol dependence	0.00306	0.00745	CcSEcCtD
Ranolazine—Diplopia—Acamprosate—alcohol dependence	0.00306	0.00743	CcSEcCtD
Ranolazine—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00302	0.0325	CbGpPWpGaD
Ranolazine—Lethargy—Naltrexone—alcohol dependence	0.00295	0.00717	CcSEcCtD
Ranolazine—CYP2D6—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00293	0.0315	CbGpPWpGaD
Ranolazine—Pain in extremity—Naltrexone—alcohol dependence	0.00289	0.00703	CcSEcCtD
Ranolazine—Blood creatinine increased—Acamprosate—alcohol dependence	0.00286	0.00696	CcSEcCtD
Ranolazine—Orthostatic hypotension—Acamprosate—alcohol dependence	0.00279	0.00678	CcSEcCtD
Ranolazine—Breast disorder—Acamprosate—alcohol dependence	0.00276	0.00671	CcSEcCtD
Ranolazine—Paraesthesia—Disulfiram—alcohol dependence	0.00274	0.00665	CcSEcCtD
Ranolazine—Somnolence—Disulfiram—alcohol dependence	0.00271	0.00659	CcSEcCtD
Ranolazine—Dehydration—Naltrexone—alcohol dependence	0.00269	0.00653	CcSEcCtD
Ranolazine—Fatigue—Disulfiram—alcohol dependence	0.00263	0.00639	CcSEcCtD
Ranolazine—Eosinophilia—Acamprosate—alcohol dependence	0.00261	0.00635	CcSEcCtD
Ranolazine—Cramp muscle—Naltrexone—alcohol dependence	0.0026	0.00633	CcSEcCtD
Ranolazine—Pancreatitis—Acamprosate—alcohol dependence	0.00259	0.00629	CcSEcCtD
Ranolazine—Gait disturbance—Citalopram—alcohol dependence	0.00259	0.00628	CcSEcCtD
Ranolazine—Coordination abnormal—Citalopram—alcohol dependence	0.00257	0.00624	CcSEcCtD
Ranolazine—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00257	0.0276	CbGpPWpGaD
Ranolazine—Acetophenazine—DRD2—alcohol dependence	0.00245	0.442	CrCbGaD
Ranolazine—Depressed level of consciousness—Citalopram—alcohol dependence	0.00244	0.00592	CcSEcCtD
Ranolazine—Erectile dysfunction—Acamprosate—alcohol dependence	0.00243	0.00591	CcSEcCtD
Ranolazine—Abdominal discomfort—Naltrexone—alcohol dependence	0.0024	0.00582	CcSEcCtD
Ranolazine—Weight decreased—Acamprosate—alcohol dependence	0.00239	0.00581	CcSEcCtD
Ranolazine—Weight decreased—Naltrexone—alcohol dependence	0.00226	0.00549	CcSEcCtD
Ranolazine—Haematuria—Acamprosate—alcohol dependence	0.00224	0.00546	CcSEcCtD
Ranolazine—CYP2D6—CYP2E1 reactions—CYP2E1—alcohol dependence	0.00222	0.024	CbGpPWpGaD
Ranolazine—Epistaxis—Acamprosate—alcohol dependence	0.00222	0.0054	CcSEcCtD
Ranolazine—Asthenia—Disulfiram—alcohol dependence	0.00219	0.00532	CcSEcCtD
Ranolazine—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00218	0.0235	CbGpPWpGaD
Ranolazine—Hallucination—Acamprosate—alcohol dependence	0.0021	0.00511	CcSEcCtD
Ranolazine—Hypoaesthesia—Acamprosate—alcohol dependence	0.0021	0.00511	CcSEcCtD
Ranolazine—Epistaxis—Naltrexone—alcohol dependence	0.0021	0.00511	CcSEcCtD
Ranolazine—Oedema peripheral—Acamprosate—alcohol dependence	0.00208	0.00506	CcSEcCtD
Ranolazine—CYP2D6—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00206	0.0222	CbGpPWpGaD
Ranolazine—Disorientation—Citalopram—alcohol dependence	0.00205	0.00498	CcSEcCtD
Ranolazine—Visual impairment—Acamprosate—alcohol dependence	0.00204	0.00495	CcSEcCtD
Ranolazine—Dizziness—Disulfiram—alcohol dependence	0.00202	0.0049	CcSEcCtD
Ranolazine—Hallucination—Naltrexone—alcohol dependence	0.00199	0.00484	CcSEcCtD
Ranolazine—Renal failure acute—Citalopram—alcohol dependence	0.00198	0.00482	CcSEcCtD
Ranolazine—Tinnitus—Acamprosate—alcohol dependence	0.00197	0.00479	CcSEcCtD
Ranolazine—Connective tissue disorder—Naltrexone—alcohol dependence	0.00197	0.00478	CcSEcCtD
Ranolazine—Hot flush—Citalopram—alcohol dependence	0.00196	0.00476	CcSEcCtD
Ranolazine—Amnesia—Citalopram—alcohol dependence	0.00195	0.00474	CcSEcCtD
Ranolazine—Menopausal symptoms—Citalopram—alcohol dependence	0.00194	0.00472	CcSEcCtD
Ranolazine—Visual disturbance—Citalopram—alcohol dependence	0.00193	0.0047	CcSEcCtD
Ranolazine—Rash—Disulfiram—alcohol dependence	0.00192	0.00467	CcSEcCtD
Ranolazine—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00192	0.0207	CbGpPWpGaD
Ranolazine—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00191	0.0206	CbGpPWpGaD
Ranolazine—Headache—Disulfiram—alcohol dependence	0.00191	0.00464	CcSEcCtD
Ranolazine—Lethargy—Citalopram—alcohol dependence	0.00187	0.00454	CcSEcCtD
Ranolazine—Eye disorder—Naltrexone—alcohol dependence	0.00187	0.00454	CcSEcCtD
Ranolazine—Tinnitus—Naltrexone—alcohol dependence	0.00186	0.00453	CcSEcCtD
Ranolazine—Cardiac disorder—Naltrexone—alcohol dependence	0.00186	0.00451	CcSEcCtD
Ranolazine—Mental disorder—Acamprosate—alcohol dependence	0.00185	0.0045	CcSEcCtD
Ranolazine—Malnutrition—Acamprosate—alcohol dependence	0.00184	0.00447	CcSEcCtD
Ranolazine—Diplopia—Citalopram—alcohol dependence	0.00183	0.00445	CcSEcCtD
Ranolazine—Pain in extremity—Citalopram—alcohol dependence	0.00183	0.00445	CcSEcCtD
Ranolazine—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00182	0.0196	CbGpPWpGaD
Ranolazine—Angiopathy—Naltrexone—alcohol dependence	0.00181	0.00441	CcSEcCtD
Ranolazine—Flatulence—Acamprosate—alcohol dependence	0.00181	0.00441	CcSEcCtD
Ranolazine—Mediastinal disorder—Naltrexone—alcohol dependence	0.0018	0.00438	CcSEcCtD
Ranolazine—Muscle spasms—Acamprosate—alcohol dependence	0.00177	0.0043	CcSEcCtD
Ranolazine—Mental disorder—Naltrexone—alcohol dependence	0.00175	0.00426	CcSEcCtD
Ranolazine—Urinary retention—Citalopram—alcohol dependence	0.00174	0.00423	CcSEcCtD
Ranolazine—Malnutrition—Naltrexone—alcohol dependence	0.00174	0.00423	CcSEcCtD
Ranolazine—Tremor—Acamprosate—alcohol dependence	0.00172	0.00419	CcSEcCtD
Ranolazine—Flatulence—Naltrexone—alcohol dependence	0.00172	0.00417	CcSEcCtD
Ranolazine—Dehydration—Citalopram—alcohol dependence	0.0017	0.00414	CcSEcCtD
Ranolazine—Angioedema—Acamprosate—alcohol dependence	0.00168	0.00409	CcSEcCtD
Ranolazine—Muscle spasms—Naltrexone—alcohol dependence	0.00167	0.00407	CcSEcCtD
Ranolazine—Orthostatic hypotension—Citalopram—alcohol dependence	0.00167	0.00407	CcSEcCtD
Ranolazine—Propranolol—HTR1B—alcohol dependence	0.00167	0.302	CrCbGaD
Ranolazine—Breast disorder—Citalopram—alcohol dependence	0.00166	0.00402	CcSEcCtD
Ranolazine—Vertigo—Acamprosate—alcohol dependence	0.00165	0.00402	CcSEcCtD
Ranolazine—Syncope—Acamprosate—alcohol dependence	0.00165	0.00401	CcSEcCtD
Ranolazine—Cramp muscle—Citalopram—alcohol dependence	0.00165	0.00401	CcSEcCtD
Ranolazine—CYP2D6—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00165	0.0177	CbGpPWpGaD
Ranolazine—Leukopenia—Acamprosate—alcohol dependence	0.00165	0.004	CcSEcCtD
Ranolazine—Vision blurred—Naltrexone—alcohol dependence	0.00164	0.00399	CcSEcCtD
Ranolazine—Tremor—Naltrexone—alcohol dependence	0.00163	0.00396	CcSEcCtD
Ranolazine—Palpitations—Acamprosate—alcohol dependence	0.00163	0.00395	CcSEcCtD
Ranolazine—Loss of consciousness—Acamprosate—alcohol dependence	0.00162	0.00393	CcSEcCtD
Ranolazine—Cough—Acamprosate—alcohol dependence	0.00161	0.0039	CcSEcCtD
Ranolazine—Angioedema—Naltrexone—alcohol dependence	0.00159	0.00387	CcSEcCtD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00157	0.0169	CbGpPWpGaD
Ranolazine—Eosinophilia—Citalopram—alcohol dependence	0.00157	0.00381	CcSEcCtD
Ranolazine—Syncope—Naltrexone—alcohol dependence	0.00156	0.00379	CcSEcCtD
Ranolazine—Anxiety—Acamprosate—alcohol dependence	0.00156	0.00379	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00156	0.00378	CcSEcCtD
Ranolazine—Pancreatitis—Citalopram—alcohol dependence	0.00155	0.00377	CcSEcCtD
Ranolazine—Palpitations—Naltrexone—alcohol dependence	0.00154	0.00374	CcSEcCtD
Ranolazine—Dry mouth—Acamprosate—alcohol dependence	0.00153	0.00372	CcSEcCtD
Ranolazine—Loss of consciousness—Naltrexone—alcohol dependence	0.00153	0.00372	CcSEcCtD
Ranolazine—Cough—Naltrexone—alcohol dependence	0.00152	0.00369	CcSEcCtD
Ranolazine—Abdominal discomfort—Citalopram—alcohol dependence	0.00152	0.00369	CcSEcCtD
Ranolazine—Confusional state—Acamprosate—alcohol dependence	0.00151	0.00368	CcSEcCtD
Ranolazine—Pancytopenia—Citalopram—alcohol dependence	0.0015	0.00365	CcSEcCtD
Ranolazine—Dysuria—Citalopram—alcohol dependence	0.00148	0.0036	CcSEcCtD
Ranolazine—Shock—Acamprosate—alcohol dependence	0.00148	0.00359	CcSEcCtD
Ranolazine—Anxiety—Naltrexone—alcohol dependence	0.00148	0.00359	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00147	0.00358	CcSEcCtD
Ranolazine—Thrombocytopenia—Acamprosate—alcohol dependence	0.00147	0.00357	CcSEcCtD
Ranolazine—Skin disorder—Acamprosate—alcohol dependence	0.00146	0.00354	CcSEcCtD
Ranolazine—Erectile dysfunction—Citalopram—alcohol dependence	0.00146	0.00354	CcSEcCtD
Ranolazine—Hyperhidrosis—Acamprosate—alcohol dependence	0.00145	0.00353	CcSEcCtD
Ranolazine—Dry mouth—Naltrexone—alcohol dependence	0.00145	0.00352	CcSEcCtD
Ranolazine—Confusional state—Naltrexone—alcohol dependence	0.00143	0.00348	CcSEcCtD
Ranolazine—Weight decreased—Citalopram—alcohol dependence	0.00143	0.00348	CcSEcCtD
Ranolazine—Anorexia—Acamprosate—alcohol dependence	0.00143	0.00348	CcSEcCtD
Ranolazine—Carvedilol—CYP2E1—alcohol dependence	0.00142	0.256	CrCbGaD
Ranolazine—Hypotension—Acamprosate—alcohol dependence	0.0014	0.00341	CcSEcCtD
Ranolazine—Shock—Naltrexone—alcohol dependence	0.0014	0.0034	CcSEcCtD
Ranolazine—Nervous system disorder—Naltrexone—alcohol dependence	0.00139	0.00339	CcSEcCtD
Ranolazine—Skin disorder—Naltrexone—alcohol dependence	0.00138	0.00335	CcSEcCtD
Ranolazine—CYP2D6—Xenobiotics—CYP2E1—alcohol dependence	0.00138	0.0148	CbGpPWpGaD
Ranolazine—Hyperhidrosis—Naltrexone—alcohol dependence	0.00137	0.00334	CcSEcCtD
Ranolazine—Insomnia—Acamprosate—alcohol dependence	0.00136	0.0033	CcSEcCtD
Ranolazine—Anorexia—Naltrexone—alcohol dependence	0.00135	0.00329	CcSEcCtD
Ranolazine—Paraesthesia—Acamprosate—alcohol dependence	0.00135	0.00328	CcSEcCtD
Ranolazine—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00135	0.0145	CbGpPWpGaD
Ranolazine—Haematuria—Citalopram—alcohol dependence	0.00135	0.00327	CcSEcCtD
Ranolazine—Dyspnoea—Acamprosate—alcohol dependence	0.00134	0.00325	CcSEcCtD
Ranolazine—Somnolence—Acamprosate—alcohol dependence	0.00133	0.00324	CcSEcCtD
Ranolazine—Epistaxis—Citalopram—alcohol dependence	0.00133	0.00324	CcSEcCtD
Ranolazine—CYP2D6—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00133	0.0143	CbGpPWpGaD
Ranolazine—Dyspepsia—Acamprosate—alcohol dependence	0.00132	0.00321	CcSEcCtD
Ranolazine—Decreased appetite—Acamprosate—alcohol dependence	0.00131	0.00317	CcSEcCtD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.0013	0.014	CbGpPWpGaD
Ranolazine—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.0013	0.00315	CcSEcCtD
Ranolazine—Bradycardia—Citalopram—alcohol dependence	0.00129	0.00314	CcSEcCtD
Ranolazine—Insomnia—Naltrexone—alcohol dependence	0.00128	0.00312	CcSEcCtD
Ranolazine—Constipation—Acamprosate—alcohol dependence	0.00128	0.00312	CcSEcCtD
Ranolazine—Paraesthesia—Naltrexone—alcohol dependence	0.00128	0.0031	CcSEcCtD
Ranolazine—Dyspnoea—Naltrexone—alcohol dependence	0.00127	0.00308	CcSEcCtD
Ranolazine—Somnolence—Naltrexone—alcohol dependence	0.00126	0.00307	CcSEcCtD
Ranolazine—Hypoaesthesia—Citalopram—alcohol dependence	0.00126	0.00306	CcSEcCtD
Ranolazine—Hallucination—Citalopram—alcohol dependence	0.00126	0.00306	CcSEcCtD
Ranolazine—Urinary tract disorder—Citalopram—alcohol dependence	0.00125	0.00304	CcSEcCtD
Ranolazine—Oedema peripheral—Citalopram—alcohol dependence	0.00125	0.00303	CcSEcCtD
Ranolazine—Connective tissue disorder—Citalopram—alcohol dependence	0.00125	0.00303	CcSEcCtD
Ranolazine—Urethral disorder—Citalopram—alcohol dependence	0.00124	0.00302	CcSEcCtD
Ranolazine—Feeling abnormal—Acamprosate—alcohol dependence	0.00124	0.00301	CcSEcCtD
Ranolazine—Decreased appetite—Naltrexone—alcohol dependence	0.00124	0.003	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.00123	0.0133	CbGpPWpGaD
Ranolazine—Gastrointestinal pain—Acamprosate—alcohol dependence	0.00123	0.00298	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00123	0.00298	CcSEcCtD
Ranolazine—Fatigue—Naltrexone—alcohol dependence	0.00122	0.00298	CcSEcCtD
Ranolazine—Visual impairment—Citalopram—alcohol dependence	0.00122	0.00297	CcSEcCtD
Ranolazine—Constipation—Naltrexone—alcohol dependence	0.00121	0.00295	CcSEcCtD
Ranolazine—Urticaria—Acamprosate—alcohol dependence	0.00119	0.0029	CcSEcCtD
Ranolazine—Abdominal pain—Acamprosate—alcohol dependence	0.00119	0.00289	CcSEcCtD
Ranolazine—Eye disorder—Citalopram—alcohol dependence	0.00118	0.00288	CcSEcCtD
Ranolazine—Tinnitus—Citalopram—alcohol dependence	0.00118	0.00287	CcSEcCtD
Ranolazine—Cardiac disorder—Citalopram—alcohol dependence	0.00118	0.00286	CcSEcCtD
Ranolazine—Feeling abnormal—Naltrexone—alcohol dependence	0.00117	0.00285	CcSEcCtD
Ranolazine—Gastrointestinal pain—Naltrexone—alcohol dependence	0.00116	0.00282	CcSEcCtD
Ranolazine—Angiopathy—Citalopram—alcohol dependence	0.00115	0.00279	CcSEcCtD
Ranolazine—Mediastinal disorder—Citalopram—alcohol dependence	0.00114	0.00278	CcSEcCtD
Ranolazine—Arrhythmia—Citalopram—alcohol dependence	0.00113	0.00275	CcSEcCtD
Ranolazine—Urticaria—Naltrexone—alcohol dependence	0.00113	0.00274	CcSEcCtD
Ranolazine—Abdominal pain—Naltrexone—alcohol dependence	0.00112	0.00273	CcSEcCtD
Ranolazine—Mental disorder—Citalopram—alcohol dependence	0.00111	0.0027	CcSEcCtD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00111	0.0119	CbGpPWpGaD
Ranolazine—Malnutrition—Citalopram—alcohol dependence	0.0011	0.00268	CcSEcCtD
Ranolazine—Flatulence—Citalopram—alcohol dependence	0.00109	0.00264	CcSEcCtD
Ranolazine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00108	0.0116	CbGpPWpGaD
Ranolazine—Asthenia—Acamprosate—alcohol dependence	0.00108	0.00262	CcSEcCtD
Ranolazine—Pruritus—Acamprosate—alcohol dependence	0.00106	0.00258	CcSEcCtD
Ranolazine—Muscle spasms—Citalopram—alcohol dependence	0.00106	0.00258	CcSEcCtD
Ranolazine—Vision blurred—Citalopram—alcohol dependence	0.00104	0.00253	CcSEcCtD
Ranolazine—Tremor—Citalopram—alcohol dependence	0.00103	0.00251	CcSEcCtD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00103	0.011	CbGpPWpGaD
Ranolazine—Asthenia—Naltrexone—alcohol dependence	0.00102	0.00248	CcSEcCtD
Ranolazine—Angioedema—Citalopram—alcohol dependence	0.00101	0.00245	CcSEcCtD
Ranolazine—Pruritus—Naltrexone—alcohol dependence	0.00101	0.00244	CcSEcCtD
Ranolazine—Dizziness—Acamprosate—alcohol dependence	0.000993	0.00241	CcSEcCtD
Ranolazine—Vertigo—Citalopram—alcohol dependence	0.000991	0.00241	CcSEcCtD
Ranolazine—Syncope—Citalopram—alcohol dependence	0.000989	0.0024	CcSEcCtD
Ranolazine—Leukopenia—Citalopram—alcohol dependence	0.000987	0.0024	CcSEcCtD
Ranolazine—Palpitations—Citalopram—alcohol dependence	0.000975	0.00237	CcSEcCtD
Ranolazine—Loss of consciousness—Citalopram—alcohol dependence	0.000969	0.00236	CcSEcCtD
Ranolazine—Cough—Citalopram—alcohol dependence	0.000962	0.00234	CcSEcCtD
Ranolazine—Vomiting—Acamprosate—alcohol dependence	0.000955	0.00232	CcSEcCtD
Ranolazine—Rash—Acamprosate—alcohol dependence	0.000947	0.0023	CcSEcCtD
Ranolazine—Dermatitis—Acamprosate—alcohol dependence	0.000946	0.0023	CcSEcCtD
Ranolazine—Headache—Acamprosate—alcohol dependence	0.000941	0.00229	CcSEcCtD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00094	0.0101	CbGpPWpGaD
Ranolazine—Dizziness—Naltrexone—alcohol dependence	0.000939	0.00228	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.000936	0.0101	CbGpPWpGaD
Ranolazine—Anxiety—Citalopram—alcohol dependence	0.000936	0.00227	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000933	0.00227	CcSEcCtD
Ranolazine—Dry mouth—Citalopram—alcohol dependence	0.000918	0.00223	CcSEcCtD
Ranolazine—Confusional state—Citalopram—alcohol dependence	0.000908	0.00221	CcSEcCtD
Ranolazine—Vomiting—Naltrexone—alcohol dependence	0.000903	0.0022	CcSEcCtD
Ranolazine—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000901	0.00971	CbGpPWpGaD
Ranolazine—Rash—Naltrexone—alcohol dependence	0.000896	0.00218	CcSEcCtD
Ranolazine—Dermatitis—Naltrexone—alcohol dependence	0.000895	0.00218	CcSEcCtD
Ranolazine—Nausea—Acamprosate—alcohol dependence	0.000892	0.00217	CcSEcCtD
Ranolazine—Headache—Naltrexone—alcohol dependence	0.00089	0.00216	CcSEcCtD
Ranolazine—Shock—Citalopram—alcohol dependence	0.000886	0.00215	CcSEcCtD
Ranolazine—Nervous system disorder—Citalopram—alcohol dependence	0.000883	0.00215	CcSEcCtD
Ranolazine—Thrombocytopenia—Citalopram—alcohol dependence	0.000881	0.00214	CcSEcCtD
Ranolazine—Skin disorder—Citalopram—alcohol dependence	0.000874	0.00213	CcSEcCtD
Ranolazine—Hyperhidrosis—Citalopram—alcohol dependence	0.00087	0.00212	CcSEcCtD
Ranolazine—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000867	0.00933	CbGpPWpGaD
Ranolazine—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000862	0.00928	CbGpPWpGaD
Ranolazine—Anorexia—Citalopram—alcohol dependence	0.000858	0.00209	CcSEcCtD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00085	0.00915	CbGpPWpGaD
Ranolazine—Nausea—Naltrexone—alcohol dependence	0.000844	0.00205	CcSEcCtD
Ranolazine—CYP2D6—Melatonin metabolism and effects—MAOA—alcohol dependence	0.000843	0.00907	CbGpPWpGaD
Ranolazine—Hypotension—Citalopram—alcohol dependence	0.000841	0.00204	CcSEcCtD
Ranolazine—CYP2D6—Biological oxidations—ADH6—alcohol dependence	0.000833	0.00897	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000824	0.00887	CbGpPWpGaD
Ranolazine—Insomnia—Citalopram—alcohol dependence	0.000814	0.00198	CcSEcCtD
Ranolazine—Paraesthesia—Citalopram—alcohol dependence	0.000808	0.00196	CcSEcCtD
Ranolazine—Dyspnoea—Citalopram—alcohol dependence	0.000803	0.00195	CcSEcCtD
Ranolazine—Somnolence—Citalopram—alcohol dependence	0.0008	0.00195	CcSEcCtD
Ranolazine—Dyspepsia—Citalopram—alcohol dependence	0.000792	0.00193	CcSEcCtD
Ranolazine—Decreased appetite—Citalopram—alcohol dependence	0.000783	0.0019	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000777	0.00189	CcSEcCtD
Ranolazine—Fatigue—Citalopram—alcohol dependence	0.000776	0.00189	CcSEcCtD
Ranolazine—Constipation—Citalopram—alcohol dependence	0.00077	0.00187	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—GRIN2B—alcohol dependence	0.000757	0.00815	CbGpPWpGaD
Ranolazine—Feeling abnormal—Citalopram—alcohol dependence	0.000742	0.0018	CcSEcCtD
Ranolazine—Gastrointestinal pain—Citalopram—alcohol dependence	0.000736	0.00179	CcSEcCtD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000723	0.00778	CbGpPWpGaD
Ranolazine—Urticaria—Citalopram—alcohol dependence	0.000715	0.00174	CcSEcCtD
Ranolazine—Abdominal pain—Citalopram—alcohol dependence	0.000712	0.00173	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000704	0.00758	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—ADH1A—alcohol dependence	0.00069	0.00743	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.00069	0.00743	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000683	0.00735	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000681	0.00733	CbGpPWpGaD
Ranolazine—Asthenia—Citalopram—alcohol dependence	0.000646	0.00157	CcSEcCtD
Ranolazine—Pruritus—Citalopram—alcohol dependence	0.000637	0.00155	CcSEcCtD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000614	0.00662	CbGpPWpGaD
Ranolazine—Dizziness—Citalopram—alcohol dependence	0.000595	0.00145	CcSEcCtD
Ranolazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.00059	0.00635	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—ADH4—alcohol dependence	0.000587	0.00632	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000581	0.00625	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000579	0.00624	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000574	0.00618	CbGpPWpGaD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000572	0.00616	CbGpPWpGaD
Ranolazine—Vomiting—Citalopram—alcohol dependence	0.000572	0.00139	CcSEcCtD
Ranolazine—Rash—Citalopram—alcohol dependence	0.000568	0.00138	CcSEcCtD
Ranolazine—Dermatitis—Citalopram—alcohol dependence	0.000567	0.00138	CcSEcCtD
Ranolazine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000565	0.00608	CbGpPWpGaD
Ranolazine—Headache—Citalopram—alcohol dependence	0.000564	0.00137	CcSEcCtD
Ranolazine—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000545	0.00587	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—GRIN2B—alcohol dependence	0.00054	0.00582	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000539	0.0058	CbGpPWpGaD
Ranolazine—Nausea—Citalopram—alcohol dependence	0.000535	0.0013	CcSEcCtD
Ranolazine—CYP2D6—Biological oxidations—ADH7—alcohol dependence	0.000499	0.00537	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GGT2—alcohol dependence	0.000479	0.00515	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—GRIN2B—alcohol dependence	0.000472	0.00508	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000464	0.005	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000463	0.00498	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000451	0.00486	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000446	0.00481	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—ADH1B—alcohol dependence	0.000438	0.00471	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000384	0.00413	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000382	0.00411	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00038	0.00409	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000374	0.00403	CbGpPWpGaD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000369	0.00398	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—MAOB—alcohol dependence	0.000363	0.00391	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—GRIN2B—alcohol dependence	0.000337	0.00362	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000326	0.00351	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000313	0.00337	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—ALDH2—alcohol dependence	0.000308	0.00332	CbGpPWpGaD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000307	0.0033	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—EP300—alcohol dependence	0.000304	0.00328	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000303	0.00327	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000286	0.00308	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00025	0.00269	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000249	0.00268	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	0.000247	0.00265	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000243	0.00262	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000237	0.00255	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GGT1—alcohol dependence	0.000226	0.00244	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—MAOA—alcohol dependence	0.000203	0.00218	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000202	0.00217	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.0002	0.00216	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—EP300—alcohol dependence	0.000194	0.00209	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000163	0.00175	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000161	0.00174	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000159	0.00171	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000148	0.00159	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ADH6—alcohol dependence	0.000142	0.00153	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000133	0.00143	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—POMC—alcohol dependence	0.000132	0.00142	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—EP300—alcohol dependence	0.000121	0.0013	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ADH1A—alcohol dependence	0.000118	0.00127	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ADH4—alcohol dependence	0.0001	0.00108	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ADH6—alcohol dependence	9.32e-05	0.001	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—POMC—alcohol dependence	8.63e-05	0.00093	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ADH7—alcohol dependence	8.54e-05	0.000919	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GGT2—alcohol dependence	8.18e-05	0.000881	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ADH1A—alcohol dependence	7.72e-05	0.000831	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ADH1B—alcohol dependence	7.49e-05	0.000806	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ADH4—alcohol dependence	6.56e-05	0.000707	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MAOB—alcohol dependence	6.2e-05	0.000668	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ADH7—alcohol dependence	5.58e-05	0.000601	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GGT2—alcohol dependence	5.35e-05	0.000576	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ALDH2—alcohol dependence	5.27e-05	0.000568	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ADH1B—alcohol dependence	4.89e-05	0.000527	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GOT2—alcohol dependence	4.48e-05	0.000483	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP2E1—alcohol dependence	4.22e-05	0.000454	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MAOB—alcohol dependence	4.06e-05	0.000437	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GGT1—alcohol dependence	3.87e-05	0.000417	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GOT1—alcohol dependence	3.87e-05	0.000417	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MAOA—alcohol dependence	3.47e-05	0.000374	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ALDH2—alcohol dependence	3.45e-05	0.000371	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GOT2—alcohol dependence	2.93e-05	0.000316	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.76e-05	0.000297	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GGT1—alcohol dependence	2.53e-05	0.000273	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GOT1—alcohol dependence	2.53e-05	0.000273	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MAOA—alcohol dependence	2.27e-05	0.000244	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—POMC—alcohol dependence	2.26e-05	0.000243	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—EP300—alcohol dependence	1.5e-05	0.000161	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—POMC—alcohol dependence	1.48e-05	0.000159	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—EP300—alcohol dependence	9.79e-06	0.000105	CbGpPWpGaD
